SK hynix (SKHY) Stock Analysis: Can HBM Leadership Outlast the Memory Cycle?

Stacked high-bandwidth memory beside an AI accelerator in a data center

SK hynix became much easier for U.S. investors to access when its American Depositary Shares began trading on Nasdaq in July 2026. The Korean company is a major producer of DRAM, NAND flash, enterprise SSDs, and high-bandwidth memory. It does not design AI accelerators like NVIDIA or AMD. Instead, it manufactures the memory that feeds … Read more

Arm Stock Analysis: How the Chip Royalty Model Turns AI Adoption Into Cash Flow

Processor architecture blueprint connecting phones, servers, vehicles, and industrial systems

Arm Holdings is one of the most important companies in computing, but it is also easy to misunderstand. Arm usually does not manufacture chips. It usually does not sell finished processors in the way NVIDIA or AMD does. Instead, it designs the instruction-set architecture, processor cores, and reusable system technology that other companies put inside … Read more

AMD Stock Analysis: Can AI Data Center Growth Outrun Its Cost of Capital?

Abstract AI data-center processors connected to servers and cash-flow bars

AMD’s latest results show a company changing scale: quarterly revenue reached $11.5 billion and Data Center revenue more than doubled year over year. The harder question is whether that growth will become durable free cash flow per diluted share—and whether the return on the capital and research required to produce it can justify the expectations … Read more

AI CapEx Comparison: Microsoft, Alphabet, Amazon & Meta

AI capital expenditure comparison across Alphabet, Microsoft, Amazon, and Meta

How do Microsoft, Alphabet, Amazon and Meta compare on AI-related capital spending? Start with the table below, which keeps each company’s reported period and spending definition visible. The figures cover company-wide infrastructure and do not isolate every AI dollar. Use the analysis that follows to connect investment with cash flow, margins and evidence of returns. … Read more

Eli Lilly vs. Novo Nordisk: GLP-1 Growth, Pipeline, Cash Flow, and Risks

Eli Lilly and Novo Nordisk GLP-1 growth, pipeline, and manufacturing comparison

Eli Lilly and Novo Nordisk are the two defining companies in the modern incretin market. Both have powerful franchises in diabetes and obesity, both are spending heavily to expand supply, and both have late-stage candidates intended to extend their leadership. Yet their latest results describe very different operating trajectories. Lilly entered 2026 with accelerating tirzepatide … Read more

Deere & Company (DE) Stock Analysis 2026: Precision Agriculture Through the Cycle

Deere (DE) stock analysis — precision agriculture equipment, satellite data, and connected farm technology

Deere combines an iconic machinery franchise with precision technology, connected equipment, aftermarket support, and customer financing. This analysis examines its latest results, recurring-revenue ambitions, competitive advantages, cycle risks, and valuation framework.